We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

46 hedge funds and large institutions have $8.33M invested in Accelerate Diagnostics in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,300% more call options, than puts

Call options by funds: $34K | Put options by funds: $1K

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

67% more capital invested

Capital invested by funds: $4.98M → $8.33M (+$3.35M)

12% more funds holding

Funds holding: 41 → 46 (+5)

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

Holders
46
Holders Change
+5
Holders Change %
+12.2%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
11
Closed
3
Calls
$34K
Puts
$1K
Net Calls
+$33K
Net Calls Change
+$10K

Top Buyers

1
AC
Armistice Capital
New York
+$730K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$234K
3
Renaissance Technologies
Renaissance Technologies
New York
+$60.9K
4
YIH
Y-Intercept (HK)
Hong Kong
+$29.4K
5
Citadel Advisors
Citadel Advisors
Florida
+$18.5K

Top Sellers

1
GAM
Griffin Asset Management
New York
-$200K
2
Group One Trading
Group One Trading
Illinois
-$15.7K
3
VF
Virtu Financial
New York
-$12K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$11.5K
5
TRCT
Tower Research Capital (TRC)
New York
-$7.95K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$3.41K -$7.95K -5,367 -73%
Morgan Stanley
27
Morgan Stanley
New York
$2.32K – – –
AAP
28
Arax Advisory Partners
Colorado
$1.71K – – –
SPIA
29
Steward Partners Investment Advisory
New York
$1.58K -$15 -10 -1%
AssetMark Inc
30
AssetMark Inc
California
$1.21K +$1.05K +710 New
HGERS
31
Householder Group Estate & Retirement Specialist
Arizona
$1K +$1.71K +1,155 New
AFG
32
Albion Financial Group
Utah
$363 – – –
National Bank of Canada
33
National Bank of Canada
Quebec, Canada
$274 – – –
RIL
34
Rothschild Investment LLC
Illinois
$274 – – –
NBT
35
Northwest Bank & Trust
Iowa
$239 – – –
BCWM
36
Bartlett & Co Wealth Management
Ohio
$171 – – –
GIA
37
GHP Investment Advisors
Colorado
$171 – – –
PMFA
38
Plante Moran Financial Advisors
Michigan
$171 – – –
Barclays
39
Barclays
United Kingdom
$171 +$148 +100 New
UBS Group
40
UBS Group
Switzerland
$68 – – –
Wells Fargo
41
Wells Fargo
California
$67 – – –
JP Morgan Chase
42
JP Morgan Chase
New York
$57 +$4 +3 +10%
PCA
43
Providence Capital Advisors
North Carolina
$7 – – –
Osaic Holdings
44
Osaic Holdings
Arizona
$5 – – –
Group One Trading
45
Group One Trading
Illinois
– -$15.7K -13,440 Closed
VF
46
Virtu Financial
New York
– -$12K -10,389 Closed
Qube Research & Technologies (QRT)
47
Qube Research & Technologies (QRT)
United Kingdom
– -$41 -35 Closed
Simplex Trading
48
Simplex Trading
Illinois
– +$233 +157 New
1
2

AXDX Hedge Fund Activity: Q3 2024 in Review

46 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2024, worth a combined $8.33M — up 67% from $4.98M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AXDX positions and 3 closed out — a net gain of 5 holders — while 4 added to existing stakes and 11 trimmed.

The largest buyer was Armistice Capital, adding an estimated $730K. The largest seller was Griffin Asset Management, cutting an estimated $200K.

  • 46 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2024, up from 41 in Q2 2024.
  • Funds reported $8.33M of Accelerate Diagnostics stock for Q3 2024, up 67% quarter-over-quarter.
  • 8 funds opened new Accelerate Diagnostics positions in Q3 2024 and 3 closed out, a net change of +5 holders.
  • The largest Accelerate Diagnostics buyer in Q3 2024 was Armistice Capital, an estimated $730K added.
  • The largest Accelerate Diagnostics seller in Q3 2024 was Griffin Asset Management, an estimated $200K sold.

Based on aggregated 13F filings for Q3 2024.